Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?

被引:4
作者
Ngiam, Jinghao Nicholas [1 ]
Al-Mubaarak, Abdurrahmaan [1 ]
Maurer-Stroh, Sebastian [2 ,3 ,4 ]
Tambyah, Paul Anantharajah [1 ,5 ]
机构
[1] Natl Univ Hlth Syst, Div Infect Dis, Dept Med, Singapore, Singapore
[2] Natl Univ Singapore, Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore
[3] Natl Univ Singapore, Infect Dis Labs, Agcy Sci Technol & Res, Singapore, Singapore
[4] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore
[5] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Infect Dis Translat Res Programme, Singapore, Singapore
基金
英国医学研究理事会;
关键词
COVID-19; omicron; Singapore; subvariant; XBB; SARS-COV-2; VARIANTS; CORONAVIRUS;
D O I
10.4103/singaporemedj.SMJ-2022-180
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
All pandemic viruses have eventually adapted to human hosts so that they become more transmissible and less virulent. The XBB Omicron subvariant is rapidly becoming the dominant strain of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in Singapore from October 2022 and is one of several variants circulating globally with the potential to dominate autumn/winter waves in different countries. The XBB Omicron subvariant has demonstrated increased transmissibility through an apparent propensity for immune evasion. This is to be expected in the natural evolution of a virus in a population highly vaccinated with a vaccine targeting the spike protein of the original Wuhan strain of the virus. This review explores the important implications of the rising prevalence of the SARS-CoV-2 Omicron subvariant for public health in Singapore and beyond.
引用
收藏
页码:658 / 664
页数:7
相关论文
共 53 条
[1]   Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19 [J].
Abramowicz, Mark .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04) :384-385
[2]   Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections [J].
Altarawneh, Heba N. ;
Chemaitelly, Hiam ;
Ayoub, Houssein H. ;
Tang, Patrick ;
Hasan, Mohammad R. ;
Yassine, Hadi M. ;
Al-Khatib, Hebah A. ;
Smatti, Maria K. ;
Coyle, Peter ;
Al-Kanaani, Zaina ;
Al-Kuwari, Einas ;
Jeremijenko, Andrew ;
Kaleeckal, Anvar H. ;
Latif, Ali N. ;
Shaik, Riyazuddin M. ;
Abdul-Rahim, Hanan F. ;
Nasrallah, Gheyath K. ;
Al-Kuwari, Mohamed G. ;
Butt, Adeel A. ;
Al-Romaihi, Hamad E. ;
Al-Thani, Mohamed H. ;
Al-Khal, Abdullatif ;
Bertollini, Roberto ;
Abu-Raddad, Laith J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (01) :21-34
[3]   Protection against the Omicron Variant from Previous SARS-CoV-2 Infection [J].
Altarawneh, Heba N. ;
Chemaitelly, Hiam ;
Hasan, Mohammad R. ;
Ayoub, Houssein H. ;
Qassim, Suelen ;
AlMukdad, Sawsan ;
Coyle, Peter ;
Yassine, Hadi M. ;
Al-Khatib, Hebah A. ;
Benslimane, Fatiha M. ;
Al-Kanaani, Zaina ;
Al-Kuwari, Einas ;
Jeremijenko, Andrew ;
Kaleeckal, Anvar H. ;
Latif, Ali N. ;
Shaik, Riyazuddin M. ;
Abdul-Rahim, Hanan F. ;
Nasrallah, Gheyath K. ;
Al-Kuwari, Mohamed G. ;
Butt, Adeel A. ;
Al-Romaihi, Hamad E. ;
Al-Thani, Mohamed H. ;
Al-Khal, Abdullatif ;
Bertollini, Roberto ;
Tang, Patrick ;
Abu-Raddad, Laith J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13) :1288-1290
[4]   One Year on: An Overview of Singapore's Response to COVID-19-What We Did, How We Fared, How We Can Move Forward [J].
Anand, S. Vivek ;
Shuy, Yao Kang ;
Lee, Poay Sian Sabrina ;
Lee, Eng Sing .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (17)
[5]   Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines [J].
Araf, Yusha ;
Akter, Fariya ;
Tang, Yan-dong ;
Fatemi, Rabeya ;
Parvez, Md Sorwer Alam ;
Zheng, Chunfu ;
Hossain, Md Golzar .
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) :1825-1832
[6]   The Coronavirus Disease 2019 (COVID-19) Pandemic [J].
Baloch, Saira ;
Baloch, Mohsin Ali ;
Zheng, Tianli ;
Pei, Xiaofang .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 250 (04) :271-278
[7]  
Cao Y, 2022, bioRxiv, DOI [10.1101/2022.09.15.507787, 10.1101/2022.09.15.507787, DOI 10.1101/2022.09.15.507787, DOI 10.1101/2022.09.15.507787V4]
[8]   A Bivalent Omicron-Containing Booster Vaccine against Covid-19 [J].
Chalkias, Spyros ;
Harper, Charles ;
Vrbicky, Keith ;
Walsh, Stephen R. ;
Essink, Brandon ;
Brosz, Adam ;
McGhee, Nichole ;
Tomassini, Joanne E. ;
Chen, Xing ;
Chang, Ying ;
Sutherland, Andrea ;
Montefiori, David C. ;
Girard, Bethany ;
Edwards, Darin K. ;
Feng, Jing ;
Zhou, Honghong ;
Baden, Lindsey R. ;
Miller, Jacqueline M. ;
Das, Rituparna .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (14) :1279-1291
[9]   SARS-CoV-2 Variants in Patients with Immunosuppression [J].
Corey, Lawrence ;
Beyrer, Chris ;
Cohen, Myron S. ;
Michael, Nelson L. ;
Bedford, Trevor ;
Rolland, Morgane .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06) :562-566
[10]  
COVID-19 update:Bivalent Pfizer and Moderna COVID-19 vaccines for booster immunization, 2022, Med Lett Drugs Ther, V64, P159